Herpes zoster in Germany: Quantifying the burden of disease
Open Access
- 16 June 2011
- journal article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 11 (1) , 173
- https://doi.org/10.1186/1471-2334-11-173
Abstract
Herpes zoster (HZ) is caused by a reactivation of the varicella-zoster-virus (VZV) and mainly affects individuals aged ≥ 50 years. Vaccines have been licensed or are under development that can protect against HZ and its main complication postherpetic neuralgia (PHN). In Germany, the burden of disease caused by HZ is not well known. To support the decision making process related to a potential vaccination recommendation, we estimated annual HZ disease burden in people aged ≥ 50 years in Germany by utilizing various data sources.Keywords
This publication has 44 references indexed in Scilit:
- Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in EnglandVaccine, 2011
- Herpes zoster: Burden of disease in FranceVaccine, 2010
- Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: A retrospective, population-based studyBMC Infectious Diseases, 2010
- Health burden and costs of obesity and overweight in GermanyThe European Journal of Health Economics, 2010
- Zoster Vaccine (Zostavax®)Drugs & Aging, 2010
- A Double-Blind, Randomized, Controlled, Multicenter Safety and Immunogenicity Study of a Refrigerator-Stable Formulation of ZostavaxClinical and Vaccine Immunology, 2008
- Herpes Zoster and Postherpetic NeuralgiaDrugs & Aging, 2008
- Pain, Medication Use, and Health-Related Quality of Life in Older Persons With Postherpetic Neuralgia: Results From a Population-Based SurveyThe Journal of Pain, 2005
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsNew England Journal of Medicine, 2005
- Acute Pain in Herpes Zoster and Its Impact on Health-Related Quality of LifeClinical Infectious Diseases, 2004